SE408712B - Sett att framstelladubbelsalter av s-adenosyl-l-metionin - Google Patents

Sett att framstelladubbelsalter av s-adenosyl-l-metionin

Info

Publication number
SE408712B
SE408712B SE7408388A SE7408388A SE408712B SE 408712 B SE408712 B SE 408712B SE 7408388 A SE7408388 A SE 7408388A SE 7408388 A SE7408388 A SE 7408388A SE 408712 B SE408712 B SE 408712B
Authority
SE
Sweden
Prior art keywords
metionin
adenosyl
double salts
making double
making
Prior art date
Application number
SE7408388A
Other languages
English (en)
Swedish (sv)
Other versions
SE7408388L (fr
Inventor
A Fiecchi
Original Assignee
Bioresearch Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT2314874A external-priority patent/IT1022036B/it
Application filed by Bioresearch Sas filed Critical Bioresearch Sas
Publication of SE7408388L publication Critical patent/SE7408388L/xx
Publication of SE408712B publication Critical patent/SE408712B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides
    • C12P19/40—Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE7408388A 1973-06-27 1974-06-26 Sett att framstelladubbelsalter av s-adenosyl-l-metionin SE408712B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2589573 1973-06-27
IT2314874A IT1022036B (it) 1974-05-24 1974-05-24 Processo per la preparazione di sali enzimatici
LU79038A LU79038A1 (fr) 1973-06-27 1978-02-09 Procede de preparation de sels enzymatiques

Publications (2)

Publication Number Publication Date
SE7408388L SE7408388L (fr) 1974-12-30
SE408712B true SE408712B (sv) 1979-07-02

Family

ID=27273344

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7408388A SE408712B (sv) 1973-06-27 1974-06-26 Sett att framstelladubbelsalter av s-adenosyl-l-metionin

Country Status (19)

Country Link
US (1) US3954726A (fr)
JP (1) JPS5235727B2 (fr)
AR (1) AR202219A1 (fr)
AT (1) AT347604B (fr)
BE (1) BE816915A (fr)
CA (1) CA1024088A (fr)
CH (1) CH592686A5 (fr)
DD (1) DD112451A5 (fr)
DE (1) DE2430999C2 (fr)
DK (1) DK137279B (fr)
FI (1) FI60218C (fr)
FR (1) FR2234891B1 (fr)
GB (1) GB1443587A (fr)
HK (1) HK31680A (fr)
IE (1) IE39517B1 (fr)
LU (1) LU79038A1 (fr)
NL (1) NL176276C (fr)
RO (1) RO64135A (fr)
SE (1) SE408712B (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR221676A1 (es) * 1974-07-12 1981-03-13 Bioresearch Sas Procedimiento para la preparacion de sales estables sulfonicas y/o sulfuricas de la s-adenosil-l-metionina,particularmente utiles como donadores especificos de metilo para las reacciones bioquimicas de transferencia del grupo ch3;asi como tambien las reacciones fundamentales en el metabolismo lipilico,protilico y glucidico
US4109079A (en) * 1975-10-16 1978-08-22 Yamasa Shoyu Kabushiki Kaisha Stabilized s-adenosyl-l-methionine preparations
GB2001976B (en) * 1977-08-03 1982-03-10 Yamasa Shoyu Kk S-adenosyl-l-methionine compositions and production thereof
JPS5428808A (en) * 1977-08-03 1979-03-03 Yamasa Shoyu Co Ltd Composition containing s-adenoyl-l-methionine and its preparation
GB2064523B (en) * 1979-12-04 1983-06-29 Kanegafuchi Chemical Ind Stable composition of s-adenosyl-l-methionine
IT1137640B (it) 1981-08-24 1986-09-10 Bioresearch Srl Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
US4376116A (en) * 1981-09-01 1983-03-08 Research Corporation Polyamine biosynthesis inhibitors
IT1139974B (it) * 1981-09-11 1986-09-24 Bioresearch Srl Derivati della s-adenosilmetionina,processo per la preparazione e composizioni terapeutiche che li contengono come principio attivo
JPS59196408U (ja) * 1983-06-16 1984-12-27 株式会社　永幸 筒形容器
IT1169773B (it) * 1983-08-24 1987-06-03 Bioresearch Spa Processo per la produzione di sali stabili della solfo-adenosil-l-metionina
IT1173992B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente idonei per uso farmaceutico orale
IT1173990B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente adatti per uso parenterale
US4794174A (en) * 1987-02-10 1988-12-27 Southern Research Institute 5'deoxy-5'-substituted adenosines
DE3874352T2 (de) * 1987-10-09 1992-12-17 Mario De Rosa Lipophile salze von s-adenosyl-l-methionin (sam) mit acyltaurinderivaten.
JPH02290896A (ja) * 1989-04-28 1990-11-30 Fuji Kagaku Kogyo Kk 新規なｓ―アデノシルメチオニン誘導体
JPH0576192U (ja) * 1991-08-27 1993-10-15 株式会社河合楽器製作所 小型電子機器におけるマイクロフオンの保持機構
JP3491938B2 (ja) * 1993-12-13 2004-02-03 キヤノン株式会社 Ｄｎａの回収方法
IT1318535B1 (it) * 2000-05-25 2003-08-27 Chementecno Srl Processo per la preparazione di sali farmaceuticamente accettabili di(ss,rs)-s-adenosil-l-metionina.
US6759395B2 (en) * 2000-12-18 2004-07-06 Orchid Chemicals & Pharmaceuticals, Ltd. Soft-gelatin capsule comprising S-adenosylmethionine and a method for producing the same
US6649753B2 (en) 2001-06-07 2003-11-18 Orchid Chemicals & Pharmaceuticals Ltd. Stable salts of S-adenosyl-L-methionine (SAMe) and the process for their preparation
WO2002102823A1 (fr) * 2001-06-14 2002-12-27 Orchid Chemicals & Pharmaceuticals Limited Sels stables de s-adenosyl-l-methionine (same) et procede de preparation
US20050272687A1 (en) * 2004-06-08 2005-12-08 Hebert Rolland F Stable S-adenosyl-l-methionine
FR2884421B1 (fr) 2005-04-15 2007-08-10 Virbac Sa Nouveaux moyens de regulation des troubles du comportement chez les animaux de compagnie
EP2151498A3 (fr) * 2005-04-20 2010-12-15 BASF Plant Science GmbH Cassettes d'expression pour expression préférentielle de semences dans des plantes
US20090012036A1 (en) * 2005-05-24 2009-01-08 Hebert Rolland F Stable S-adenosyl-L-methionine
ITRM20050344A1 (it) * 2005-06-30 2007-01-01 Luca Maria De Sali o complessi di sostanze metil-donatrici con acido fitico o suoi derivati e relativo metodo di sintesi.
CN101374529B (zh) * 2006-01-17 2012-08-08 三菱瓦斯化学株式会社 使s-腺苷-l-甲硫氨酸稳定化的方法以及稳定化后的组合物
ITMI20060629A1 (it) * 2006-03-31 2007-10-01 Daniele Giovannone Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento
US20090088404A1 (en) * 2007-01-31 2009-04-02 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
US20090197824A1 (en) * 2008-01-31 2009-08-06 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
JP2010518021A (ja) * 2007-01-31 2010-05-27 メチレーション・サイエンシーズ・インターナショナル・ソサイアティーズ・ウィズ・リストリクティッド・ライアビリティ Ｓ−アデノシルメチオニンの持続放出医薬製剤
ITMI20071374A1 (it) * 2007-07-10 2009-01-11 Gnosis Spa Sali stabili di s-adenosilmetionina e processo per il loro ottenimento.
US20100004191A1 (en) * 2008-07-01 2010-01-07 Rolland F Hebert Compositions of S-adenosyl-L-methionine.
EP2189154A1 (fr) 2008-11-25 2010-05-26 Gnosis S.p.A. Comprimés effervescents et granulés solubles dans la bouche de S-adénosy-L-méthionine et son procédé de préparation
IT1393331B1 (it) * 2009-02-09 2012-04-20 Graal S R L Composizioni orosolubili e/o effervescenti contenenti almeno un sale di s-adenosilmetionina (same)
US20110027342A1 (en) 2009-07-28 2011-02-03 Msi Methylation Sciences, Inc. S-adenosylmethionine formulations with enhanced bioavailability
US8329208B2 (en) 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
US9534010B2 (en) 2013-01-16 2017-01-03 Hebert Sam-E Llc Stable indole-3-propionate salts of S-adenosyl-L-methionine
WO2014163150A1 (fr) * 2013-04-05 2014-10-09 ライオン株式会社 Composition à usage interne

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642772A (en) * 1968-09-04 1972-02-15 Boehringer Mannheim Gmbh Process for preparing s-adenosyl homocysteine
DE1803978C2 (de) * 1968-10-18 1985-05-02 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Gewinnung von S-Adenosyl-l-methionin und S-Adenosyl-l-ethionin
IE37913B1 (en) * 1972-08-02 1977-11-09 Bioresearch Sas Salt of s-adenosyl-l-methionine

Also Published As

Publication number Publication date
CH592686A5 (fr) 1977-11-15
ATA532574A (de) 1978-05-15
IE39517B1 (en) 1978-10-25
SE7408388L (fr) 1974-12-30
BE816915A (fr) 1974-10-16
LU79038A1 (fr) 1978-06-26
JPS5235727B2 (fr) 1977-09-10
AR202219A1 (es) 1975-05-23
HK31680A (en) 1980-06-20
AU7068974A (en) 1976-01-08
CA1024088A (fr) 1978-01-10
NL7408688A (fr) 1974-12-31
US3954726A (en) 1976-05-04
DK137279C (fr) 1978-07-17
DK342974A (fr) 1975-03-17
DD112451A5 (fr) 1975-04-12
DE2430999A1 (de) 1975-01-16
IE39517L (en) 1974-12-27
DK137279B (da) 1978-02-13
RO64135A (fr) 1978-11-15
FI60218C (fi) 1981-12-10
NL176276C (nl) 1985-03-18
JPS5076215A (fr) 1975-06-21
FI60218B (fi) 1981-08-31
DE2430999C2 (de) 1982-06-09
NL176276B (nl) 1984-10-16
FR2234891A1 (fr) 1975-01-24
FI195474A (fr) 1974-12-28
FR2234891B1 (fr) 1977-03-11
AT347604B (de) 1979-01-10
GB1443587A (en) 1976-07-21

Similar Documents

Publication Publication Date Title
SE408712B (sv) Sett att framstelladubbelsalter av s-adenosyl-l-metionin
SE398876B (sv) Sett att framstella basiska 1,4-dihydropyridinkarbonsyraestrar
SE407577B (sv) Sett att framstella metallsalter av dialkyltiofosforsyra
SE7808959L (sv) Forfarande for framstellning av dylenoxid
SE399053B (sv) Sett att framstella polykristallin bornitrid
SE7408486L (sv) Sett att framstella poperazinyl-kinoxalinforeningar.
SE408172B (sv) Sett att framstella kristallint l-pyroglutamyl-l-histidyl-l-prolinamidtartrat
SE398880B (sv) Sett att framstella basiskt substituerade 3-bensoyl-bensofuranderivat
SE410607B (sv) Sett att framstella pregnan-21-syraderivat
SE403478B (sv) Sett att framstella 2,2,6,6-tetrametyl-4-oxopiperidin
SE407939B (sv) Sett att framstella 7-fluorsubstituerade fentiaziner med forlengd neurolopetisk effekt
SE406327B (sv) Sett att framstella d-homo-1,4-pregnadien-3,20-dioner
SE388420B (sv) Sett att framstella cyklopropylmetylaminderivat
SE7603276L (sv) Sett att framstella prostansyraderivat
SE403373B (sv) Sett att framstella aminosubstituerade tetracykliska foreningar
SE401187B (sv) Sett att framstella deltaŸ4-3-ketosteroid-17-propiolakton
SE397190B (sv) Sett att framstella substituerade dibensocykloheptener
SE399712B (sv) Sett att framstella pregnansyraderivat
SE409458B (sv) Sett att framstella 7-amino-desacetoxi-cefalosporansyra
SE387944B (sv) Sett att framstella xanton-2-karbonsyraforeningar
SE387111B (sv) Sett att framstella bensoylfenylguanidiner
SE403107B (sv) Sett att framstella 6-substituerade 3-etoxi-karbonyl hydrazino-pyridaziner
SE393620B (sv) Sett att framstella perlor av karbamid-formaldehydharts
SE404192B (sv) Sett att framstella 3 beta-cykloalkyloxi-16 alfa-cyanopregn-5-en-20-oner
SE385012B (sv) Sett att framstella 4,9,11 - trien-steroid-derivat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7408388-2

Effective date: 19940710

Format of ref document f/p: F